Rustin, Pierre

Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment

Goncalves, S., Paupe, V., Dassa, E. P., & Rustin, P. (2008) · BMC Neurology

Neurological diseases and metabolismGenetic Neurodegenerative Diseases

Cited by 66

Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives

El‐Khoury, R., Kemppainen, K. K., Dufour, E., Szibor, M., Jacobs, H. T., & Rustin, P. (2014) · British Journal of Pharmacology

Mitochondrial Function and PathologyMetabolism and Genetic Disorders

Cited by 56

Molecular insights into Friedreich's ataxia and antioxidant-based therapies

Rötig, A., Sidi, D., Munnich, A., & Rustin, P. (2002) · Trends in Molecular Medicine

Genetic Neurodegenerative DiseasesMitochondrial Function and Pathology

Cited by 46

Cells Lacking the Fumarase Tumor Suppressor Are Protected from Apoptosis through a Hypoxia-Inducible Factor-Independent, AMPK-Dependent Mechanism

Bardella, C., Olivero, M., Lorenzato, A., Geuna, M., Adam, J., O'Flaherty, L., Rustin, P., Tomlinson, I., Pollard, P. J., & Di Renzo, M. F. (2012) · Molecular and Cellular Biology

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 33